Latest Insider Transactions at Aziyo Biologics, Inc. (AZYO)
This section provides a real-time view of insider transactions for Aziyo Biologics, Inc. (AZYO). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of AZIYO BIOLOGICS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of AZIYO BIOLOGICS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 10
2024
|
Matthew Ferguson CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
10,527
-3.28%
|
$42,108
$4.14 P/Share
|
|
Sep 10
2024
|
Matthew Ferguson CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
29,500
+8.41%
|
-
|
|
Sep 10
2024
|
C Randal Mills PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
9,664
-3.67%
|
$38,656
$4.14 P/Share
|
|
Sep 10
2024
|
C Randal Mills PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
27,084
+9.32%
|
-
|
|
Sep 10
2024
|
Michelle Le Roux Williams CHIEF SCIENTIFIC OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
3,951
-6.19%
|
$15,804
$4.14 P/Share
|
|
Sep 10
2024
|
Michelle Le Roux Williams CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+16.38%
|
-
|
|
Aug 12
2024
|
Matthew Ferguson CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
17,840
-5.8%
|
$35,680
$2.84 P/Share
|
|
Aug 12
2024
|
Matthew Ferguson CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+13.97%
|
-
|
|
Aug 12
2024
|
Michelle Le Roux Williams CHIEF SCIENTIFIC OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
15,800
-23.55%
|
$31,600
$2.84 P/Share
|
|
Aug 12
2024
|
Michelle Le Roux Williams CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+42.7%
|
-
|
|
Aug 12
2024
|
C Randal Mills PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
58,659
-20.06%
|
$117,318
$2.84 P/Share
|
|
Aug 12
2024
|
C Randal Mills PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
162,500
+35.72%
|
-
|
|
Jul 31
2024
|
Matthew Ferguson CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
105,080
+28.96%
|
$105,080
$1.43 P/Share
|
|
Jul 30
2024
|
High Cape Capital, L.P. Director |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
2,101,577
+18.76%
|
$2,101,577
$1.43 P/Share
|
|
Jul 30
2024
|
High Cape Capital, LLC > 10% Shareholder |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
2,101,577
+18.76%
|
$2,101,577
$1.43 P/Share
|
|
Jun 21
2024
|
C Randal Mills PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
8,019
-5.81%
|
$24,057
$3.5 P/Share
|
|
Jun 21
2024
|
C Randal Mills PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
22,473
+14.01%
|
-
|
|
Jun 10
2024
|
C Randal Mills PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
19,327
-14.33%
|
$57,981
$3.47 P/Share
|
|
Jun 10
2024
|
C Randal Mills PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
54,167
+28.66%
|
-
|
|
Jun 10
2024
|
Matthew Ferguson CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
8,920
-5.52%
|
$26,760
$3.47 P/Share
|
|
Jun 10
2024
|
Matthew Ferguson CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+13.39%
|
-
|
|
Jun 10
2024
|
Michelle Le Roux Williams CHIEF SCIENTIFIC OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
7,900
-31.6%
|
$23,700
$3.47 P/Share
|
|
Jun 10
2024
|
Michelle Le Roux Williams CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+50.0%
|
-
|
|
Mar 08
2024
|
Matthew Ferguson CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
528
-0.43%
|
$1,584
$3.24 P/Share
|
|
Mar 08
2024
|
Matthew Ferguson CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,288
+1.05%
|
-
|
|
Dec 28
2023
|
High Cape Capital, L.P. Director |
SELL
Other acquisition or disposition
|
Indirect |
1,436,077
-17.03%
|
-
|
|
Dec 28
2023
|
High Cape Capital, LLC > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
1,436,077
-17.03%
|
-
|
|
Sep 21
2023
|
Matthew Ferguson CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
70,053
+36.76%
|
-
|
|
Jun 21
2023
|
C Randal Mills PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
7,772
-11.03%
|
$15,544
$2.41 P/Share
|
|
Jun 21
2023
|
C Randal Mills PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
22,474
+24.18%
|
-
|
|
Apr 27
2023
|
C Randal Mills PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
44,947
+48.35%
|
-
|
|
Mar 27
2023
|
Birchview Capital, LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
10,000
+0.6%
|
$10,000
$1.59 P/Share
|
|
Mar 24
2023
|
Birchview Capital, LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
20,000
+0.6%
|
$20,000
$1.35 P/Share
|
|
Mar 23
2023
|
Birchview Capital, LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
110,000
+3.22%
|
$110,000
$1.49 P/Share
|
|
Mar 09
2023
|
Thomas Englese CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
289
-1.59%
|
$1,156
$4.3 P/Share
|
|
Mar 08
2023
|
Thomas Englese CHIEF COMMERCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
937
+4.89%
|
-
|
|
Mar 08
2023
|
Matthew Ferguson CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,287
+2.69%
|
-
|
|
Dec 15
2022
|
David Colpman |
BUY
Open market or private purchase
|
Direct |
3,098
+50.0%
|
$9,294
$3.9 P/Share
|
|
Dec 09
2022
|
Brigid Makes |
BUY
Open market or private purchase
|
Direct |
2,000
+50.0%
|
$6,000
$3.65 P/Share
|
|
Dec 08
2022
|
Birchview Capital, LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
13,061
+0.43%
|
$39,183
$3.79 P/Share
|
|
Dec 07
2022
|
Birchview Capital, LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
44,000
+1.44%
|
$132,000
$3.58 P/Share
|
|
Dec 05
2022
|
High Cape Capital, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
735,000
+11.61%
|
$2,940,000
$4.75 P/Share
|
|
Dec 05
2022
|
Matthew Ferguson CHIEF FINANCIAL OFFICER |
BUY
Open market or private purchase
|
Direct |
22,000
+17.94%
|
$88,000
$4.18 P/Share
|
|
Dec 02
2022
|
Matthew Ferguson CHIEF FINANCIAL OFFICER |
BUY
Open market or private purchase
|
Direct |
6,000
+20.54%
|
$24,000
$4.03 P/Share
|
|
Dec 01
2022
|
Birchview Capital, LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
40,000
+2.67%
|
$160,000
$4.75 P/Share
|
|
Sep 08
2022
|
Matthew Ferguson CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
4,798
-21.79%
|
$33,586
$7.3 P/Share
|
|
Sep 08
2022
|
Matthew Ferguson CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
13,874
+38.66%
|
-
|
|
Sep 08
2022
|
Peter G Edwards GENERAL COUNSEL |
SELL
Payment of exercise price or tax liability
|
Direct |
1,127
-24.37%
|
$7,889
$7.3 P/Share
|
|
Sep 08
2022
|
Peter G Edwards GENERAL COUNSEL |
BUY
Exercise of conversion of derivative security
|
Direct |
4,625
+50.0%
|
-
|
|
Sep 08
2022
|
Thomas Englese CHIEF COMMERCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
4,728
-21.49%
|
$33,096
$7.3 P/Share
|